Review Article |
| |
IJMDC. 2020; 4(1): 240-243 The effect of Sitagliptin on carotid artery atherosclerosis in type2 diabetes mellitus: a systematic reviewMaryam Hussain Al-Ayesh, Abdullah Jafar Albariqi, Fatimah Salman Alramadhan, Abdullah Ibrahim Mohammed Alfawzan, Manal Mustafa Alghazal, Majed Abdulaziz Almajdui. Abstract | | | | Besides the diet and lifestyle modifications usually administered during T2D therapy, oral hypoglycemic drugs is also found to play an important role. Metformin is usually preferred as an initial pharmacological agent for T2D and if metformin monotherapy fails to achieve or maintain the hemoglobin A1c within a period of 3-6 months, usually a second drug is added to control glycemia. Among the add-on therapy options available, Sitagliptin, dipeptidyl peptidase-4 inhibitors are one of the recent and widely used drugs. The current review was aimed at exploring the effect of Sitagliptin on carotid artery atherosclerosis in type 2 diabetic patients. Multiple databases were employed in the literature review, which focused on studies that either reported the association or non-association of a Sitagliptin with carotid artery atherosclerosis. Using appropriate search terms, 8 articles published between analyzed and selected 18 articles published between the years of 2012-2018. The current systematic review concludes that Sitagliptin could be considered as a promising therapy for atherosclerosis in type 2 diabetes mellitus patients.
Key words: Sitagliptin, T2DM, atherosclerosis, carotid artery thickness
|
|
|
|